Cite
HARVARD Citation
Yardley, D. et al. (2015). Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Metastatic Breast Cancer Previously Treated With Chemotherapy and 2 or More HER2-Targeted Agents. Cancer journal. 21 (5), p. . [Online].